ARMUZZI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2769
EU - Europa 501
AF - Africa 65
AS - Asia 36
OC - Oceania 1
Totale 3372
Nazione #
US - Stati Uniti d'America 2758
FR - Francia 207
NL - Olanda 117
GB - Regno Unito 66
NG - Nigeria 65
DE - Germania 48
BE - Belgio 31
IT - Italia 18
CA - Canada 11
TR - Turchia 8
HK - Hong Kong 6
SG - Singapore 6
IL - Israele 5
JP - Giappone 5
CN - Cina 4
FI - Finlandia 3
RO - Romania 3
AT - Austria 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
IR - Iran 1
MK - Macedonia 1
PL - Polonia 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 3372
Città #
Chandler 1596
Lawrence 390
Princeton 390
Paris 206
Wilmington 164
Amsterdam 117
Benin City 65
London 65
San Mateo 60
Ann Arbor 45
Brussels 30
Leawood 25
Fairfield 18
Woodbridge 17
Hanover 15
Frankfurt am Main 13
Toronto 11
Berlin 10
Boardman 8
Kocaeli 8
Norwalk 5
Campobasso 4
Singapore 4
Beijing 3
Helsinki 3
Hirakata 3
Seattle 3
Ashburn 2
Cambridge 2
Milan 2
Santa Clara 2
Vienna 2
Augusta 1
Bitola 1
Buffalo 1
Clearwater 1
Dalsjoefors 1
Genoa 1
Henderson 1
Kemerovo 1
La Canada Flintridge 1
Las Vegas 1
Livorno 1
Potomac 1
Raleigh 1
Redmond 1
Salt Lake City 1
San Diego 1
Somerville 1
Trento 1
Uppsala 1
Xiamen 1
Totale 3308
Nome #
Adalimumab in active ulcerative colitis: A "real-life" observational study 37
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 34
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease 32
Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting 30
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate. 30
13C-Breath Tests in the study of microsomal liver function 28
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease 27
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study 27
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission 26
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 26
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial 25
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 25
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment 24
FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF alpha Agents 24
13C-breath tests in the study of mitochondrial liver function 23
Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis 23
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 23
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease 23
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 22
The PROSIT-BIO Cohort of the IG-IBD: A Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab BioSimilars 22
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use 22
Disease patterns in late-onset ulcerative colitis: Results from the " IG-IBD ""AGED study""" 21
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open 21
Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease 21
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease. Sandborn WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, Van Assche G, D'Haens G, Schreiber S, Colombel JF, Lewis JD, Ghosh S, Armuzzi A, Scherl E, Herfarth H, Vitale L, Mohamed MF, Othman AA, Zhou Q, Huang B, Thakkar RB, Pangan AL, Lacerda AP, Panes J 20
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 20
Risk factor analysis for therapy related adverse events and infections in elder patients with Inflammatory Bowel Disease; An analysis from the IG-IBD aged study 19
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naive Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study 18
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 16
The intercellular adhesion molecule-1 polymorphisms in IBD 16
COMPLEX PERIANAL FISTULIZING CROHN'S DISEASE: LONG-TERM EFFICACY OF COMBINED SETON PLACEMENT AND ANTI TNF-ALPHA AGENTS ALONE OR ASSOCIATED WITH IMMUNOSUPPRESSANTS 15
Long-term scheduled therapy with infliximab in inflammatory bowel disease 15
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 15
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery 15
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 14
HELICOBACTER-PYLORI GASTRITIS WITH CYTOTOXIN ASSOCIATED PROTEIN ANTIBODIES (CAGA) - A COMPUTER-AIDED EVALUATION OF INFLAMMATORY CELL INFILTRATION IN THE LAMINA PROPRIA, ATROPHIC GASTRITIS AND ACQUIRED MALT 14
Adalimumab in the treatment of immune-mediated diseases 14
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 14
Activity of Crohn's disease and small bowel contract-enhanced ultrasound findings 14
Difference in treatment outcomes between clinical trials and "real-life" clinical practice: ustekinumab in ulcerative colitis 14
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD 14
Incidence and symptoms related to Helicobacter pylori infection in dyspeptic patients 13
H-pylori gastric infection and rheumatic diseases 13
Gender affects 13C-ketoisocaproic breath test for liver mitochondrial function 13
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 13
Aminopyrine and methacetin 13C-breath tests to assess hepatic function in HCV-related chronic liver disease 13
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates 13
H-pylori poliantibiotic resistant strains in dyspeptic patients not eradicated by two consecutive triple eradication regimens 13
Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure 12
Helicobacter pylori eradication ameliorates migraine: An extended follow up study 12
Anti-CagA antibodies are associated with atrophic gastritis in a population at high gastric cancer risk: a morphometric study by computerized image analysis 12
Helicobacter pylori-related diseases 12
A novel pathogenic role for microvasculature in inflammatory bowel disease 12
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 12
Aminopyrine and methacetin breath tests in HCV-related chronic liver disease 12
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 12
Ustekinumab for treating ulcerative colitis: an expert opinion 12
Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement 11
Occurrence of inflammatory bowel disease in central Italy: a study based on health information systems 11
3-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure H-pylori infection 11
Infliximab in Steroid-Dependent Ulcerative Colitis 11
C-13-methacetin breath test in patients with nonalcoholic steatohepatitis 11
Reply to Dr. Kotze's and Dr. Yamamoto's letter 11
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 11
Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease 11
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results 11
Reply to Dr. Joob et al.'s letter 11
Seroprevalence of hepatitis A virus and Helicobacter pylori infections in the general population of a developed European country (the San Marino study): evidence for similar pattern of spread 11
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study 11
A multistep assessment of human liver mitochondrial function through C-13-ketoisocaproate and C-13-octanoate breath tests 11
Use of biosimilars in inflammatory bowel diseases: A survey among the clinicians members of the Italian Group for the Study of Inflammatory Bowel Disease (IGIBD) 10
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study 10
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report 10
Combination therapy in inflammatory bowel disease - from traditional immunosuppressors towards the new paradigm of dual targeted therapy 10
The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review 10
Haplotypic analysis of heat shock protein 70 (HSP70) single nucleotide polymorphisms (SNPs) in susceptibility and phenotype of inflammatory bowel disease (IBD) 10
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study 10
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 10
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI Survey 10
INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA THERAPY: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE 10
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling? 10
Gender affects C-13-ketoisocaproic acid breath test 10
C-13-methionine breath tests for mitochondrial liver function assessment 10
Importance of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis 10
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report 10
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study 10
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy 10
Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice 10
Assessment of liver mitochondrial beta-oxidation by sodium C-13-octanoate breath test 10
Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease 10
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 10
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results 10
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease 10
Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC 10
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology 10
International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey 10
High prevalence of Helicobacter pylori infection in recurrent spontaneous abortion 10
Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease 10
Study of liver function in healthy elderly subjects using the C-13-methacetin breath test 10
Acute pancreatitis and parathyroid carcinoma: a case report and literature review 10
Totale 1525
Categoria #
all - tutte 27656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0000 00 00 0007
2020/2021296 1304 093 3820 6740129
2021/2022210 421039 30 623 16174743
2022/20232880 84255424569 431546 130 0000
Totale 3393